Taken together, these results provide a molecular explanation for the defects associated with Ruijs-Aalfs syndrome and shed light on how mutations in SPRTN can contribute to segmental progeroid syndrome, genome instability and hepatocellular carcinoma development (Figure 6). The gene discussed is SPRTN; the disease is progeroid features-hepatocellular carcinoma predisposition syndrome.